Locquet, M., Beaudart, C., Pétermans, J., Reginster, J., & Bruyère, O. (2019). EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences.
Chicago-Zitierstil (17. Ausg.)Locquet, Médéa, Charlotte Beaudart, Jean Pétermans, Jean‐Yves Reginster, und Olivier Bruyère. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.
MLA-Zitierstil (9. Ausg.)Locquet, Médéa, et al. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.